Does systemic antibiotic prophylaxis prior to the placement of totally implantable venous access devices reduce early infection? A retrospective study of 1,485 cases at a large academic institution - 25/12/19
Highlights |
• | Prophylactic antibiotic use for totally implantable venous access devices (TIVADs) placement is variable. |
• | Central line–associated bloodstream infections after TIVAD placement is rare. |
• | Giving antibiotics before TIVAD placement had no effect on early infection. |
Résumé |
Background |
To determine if ending the practice of administering prophylactic antibiotics prior to the placement of totally implantable venous access devices (TIVADs) is correlated with an increase in 30-day bloodstream infection–related TIVADs removals.
Methods |
The practice of administering prophylactic antibiotics prior to the placement of TIVADs ended in July 2013 at our institution. We compiled a list of patients who had TIVADs placed between July 2010 and July 2016 and cross-referenced this list to a list of patients who had TIVADs removed between July 2010 and August 2016 to evaluate the 30-day bloodstream infection–related TIVAD removals. Retrospective chart review of all patients was performed to collect demographic information, indication for placement, and type of antibiotic administered, if applicable.
Results |
Over the study period of 6 years, a total of 1,513 TIVADs were placed, of which 28 cases were excluded because of death within 30 days unrelated to TIVAD placement. Of the remaining 1,485 cases, 733 TIVADs were placed in 709 unique patients with prophylactic antibiotic treatment and 752 TIVADs were placed in 709 unique patients without treatment. A total of 8 patients were identified to have TIVADs removed within 30 days owing to infection, of which 4 patients were treated with prophylactic antibiotics. The odds of infection-related removals without prophylactic treatment compared with prophylactic treatment was 0.97 (95% confidence interval, 0.24-3.91; P = .97).
Conclusions |
Ending the practice of administrating systemic antibiotic prophylaxis prior to the placement of TIVADs had no effect on the 30-day bloodstream infection–related TIVAD removals rate at our institution. We do not recommend the use of prophylactic antibiotics for the placement of TIVAD.
Le texte complet de cet article est disponible en PDF.Key Words : Chest port, Prophylactic, Systemic infection, CLABSI
Plan
| Conflicts of interest: None to report. |
Vol 48 - N° 1
P. 95-99 - janvier 2020 Retour au numéro
Article précédent
- Regional differences in temporal incidence of Clostridium difficile infection: a systematic review and meta-analysis
- Jeffery Ho, Sunny H. Wong, Vijaya C. Doddangoudar, Maureen V. Boost, Gary Tse, Margaret Ip
- Efficacy of a novel ultraviolet light-emitting diode device for decontamination of shared pens in a health care setting
- Erica Emig, Heba Alhmidi, Yilen K. Ng-Wong, Thriveen S.C. Mana, Jennifer L. Cadnum, Curtis J. Donskey
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?